{"id":"NCT00894556","sponsor":"Organon and Co","briefTitle":"A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine (0462-087)","officialTitle":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Crossover Trial to Evaluate the Efficacy and Tolerability of Rizatriptan 10 mg for the Treatment of Acute Migraine in Sumatriptan Non-Responders","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-06-10","primaryCompletion":"2010-01-12","completion":"2010-01-12","firstPosted":"2009-05-07","resultsPosted":"2011-01-20","lastUpdate":"2024-05-10"},"enrollment":109,"design":{"allocation":"RANDOMIZED","model":"CROSSOVER","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Acute Migraine"],"interventions":[{"type":"DRUG","name":"rizatriptan","otherNames":[]},{"type":"DRUG","name":"Comparator: Placebo","otherNames":[]},{"type":"DRUG","name":"Comparator: Sumatriptan","otherNames":[]}],"arms":[{"label":"Treatment Sequence A","type":"EXPERIMENTAL"},{"label":"Treatment Sequence B","type":"EXPERIMENTAL"},{"label":"Treatment Sequence C","type":"EXPERIMENTAL"},{"label":"Baseline Phase","type":"OTHER"}],"summary":"A study to provide evidence supporting the benefit of Rizatriptan in patients who have an inadequate response to sumatriptan.","primaryOutcome":{"measure":"Pain Relief (PR)","timeFrame":"2 hours post dose","effectByArm":[{"arm":"Rizatriptan","deltaMin":102,"sd":null},{"arm":"Placebo","deltaMin":21,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":15},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21078681"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":102},"commonTop":["Dizziness - Baseline Phase","Dizziness - Treatment Phase","Nausea - Baseline Phase","Nausea - Treatment Phase","Chest discomfort - Baseline Phase"]}}